University of Wollongong

Research Online
University of Wollongong Thesis Collection
1954-2016

University of Wollongong Thesis Collections

1980

Analysis of zinc in biological fluids : determinations of serum zinclevels in
normals and patients suffering from myocardial infarctionand deep vein
thrombosis
Joseph Shing Leung
University of Wollongong
Follow this and additional works at: https://ro.uow.edu.au/theses
University of Wollongong
Copyright Warning
You may print or download ONE copy of this document for the purpose of your own research or study. The University
does not authorise you to copy, communicate or otherwise make available electronically to any other person any
copyright material contained on this site.
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised,
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court
may impose penalties and award damages in relation to offences and infringements relating to copyright material.
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the
conversion of material into digital or electronic form.
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily
represent the views of the University of Wollongong.

Recommended Citation
Leung, Joseph Shing, Analysis of zinc in biological fluids : determinations of serum zinclevels in normals
and patients suffering from myocardial infarctionand deep vein thrombosis, Master of Science thesis,
Department of Chemistry, University of Wollongong, 1980. https://ro.uow.edu.au/theses/2622

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

ANALYSIS OF ZINC IN BIOLOGICAL FLUIDS
"Determinations of Serum Zinc Levels in'Normals
and Patients suffering from Myocardial
Infarction and Deep Vein Thrombosis"

A thesis submitted in fulfilment of the
requirements for the award of the degree of

MASTER OF SCIENCE

from

TELE UNIVERSITY OF WOLLONGONG

by

JOSEPH SHING FUNG LEUNG, B. Sc.
lì' Y Of
VKy.l-^ O N é

1 . ' 'Y
DEPARTMENT OF CHEMISTRY

1980

TABLE OF CONTENTS

Introduction

Result and Discussion

^

.19

Tables and Figures

32

Experimental

48

Bibliography

60

Acknowledgement

.68

SUMMARY

Atomic Absorption Spectroscopy with a Carbon Rod
Atomiser has been used to determine serum zinc levels in
normal subjects and in patients suffering from myocardial
infarction and deep vein thrombosis.

The results suggest

that the condition of myocardial infarction and deep vein
thrombosis may be associated with a reduced serum zinc
level.
The value of oral zinc therapy for deep vein
thrombosis has been evaluated.

A seven day supplementation

with 15mg zinc sulphate per day is sufficient to bring
serum zinc levels back to normal values.

In addition,

this work suggests that patients suffering from deep vein
thrombosis may benefit clinically from a course of zinc
supplementation•

INTRODUCTION

Many inorganic metals such as sodium, potassium,
calcium and magnesium play an important role in biological
systems.

Sodium and potassium are the major cations in the

body fluid and sodium is the major cation present in the
extracellular fluid.

These cations are responsible for

maintaining the normal osmotic equilibrium of the cells.
For example, in the healthy state, the volume and composition of various body fluid compartments is maintained within
physiological limits and fluid exchanges across the cell
wall are conducted in a state of osmotic equilibrium.

If

this equilibrium is disturbed, physiological balance of the
system cannot be maintained and life may terminate.
In the normal state, the concentration of sodium in the
plasma is about 142nmol/L and hyponatremia which means a
decreased level of sodium is associated with a variety of
conditions such as Addison disease, dehydration, chronic
coronary inadequacy and myocardial infarction.

In some

other conditions, hypernatremia i.e. an increased sodium
level can occur.

For example in patients with nephrotic

syndrome^, the kidney fails to eliminate a normal amount of
water and salt and in patients suffering from both acute
and chronic disease of the liver the impaired renal excretion of sodium is due to the inadequate removal of anti
diuretic hormone and aldosterone from the circulation.
In a healthy human there is a low level of potassium
in the serum, the mean value being 4.2nmol/L.

There are

many circumstances which can lead to an abnormal accumulation of potassium.

For example, trauma or destruction of

muscle cells usually lead to a massive transfer of potassium

from the intracellular fluids to the serum.

Respiratory

distress syndrome which leads to metabolic acidosis usually
has a high serum potassium level associated with it.
nocortical insufficiency

Adre-

(Addison disease) also results in

decreased renal excretion of potassium and thus increased
level of serum potassium are observed.

Hyperaldosternism

or the excess excretion of the aldosterone hormone results
in a markedly reduced serum potassium level.
Calcium is another important element in the human body
with 90% of it located in the skeletal system.

Calcium is

maintained at a relatively constant level at about 2.5nmol/L
in most of the body fluids.

One of the most important

function of calcium ion is its regulation of nerve and muscle
excitability. "Calcium is essential for blood clotting and
the formation of thromboplastin from platelet and plasma
percursors as well as the conversion of prothrombin require
calcium.

In many diseased states, the serum concentration

of calcium is affected, for example, high calcium levels or
hypercalcemia is observed in hyperparathyrodism,
and Hodgkin disease.

sarcoidosis

While low calcium levels or Hypocal-

cemia, is a feature of diminised parathyroid function or
hypoparathyroidism.

This lack of circulation of calcium,

caused by decrease of parathyroid hormone, leads to a state
of neuro-muscular hyper-irritability or tetany.

A signifi-

cant decrease of calcium level also occurs in acute pancreaties.
Magnesium ion also occupies a central role in metabolism
as it serves as an activator of a number of enzymatic
reactions.

The serum concentration of magnesium in normals

has a mean value of 1.25nmol/L.

Magnesium exerts a neuro-

muscular effect on the nervous system, in which it causes a
curare-like action as it decreases the sensitivities of the
motor end plate to actylcholine and decreases the liberation
of actylcholine at the neuromuscular junction and synpathetic
ganglia.

Many enzymes, such as hexokinase and fructokinase

are activated by magnesium.

Magnesium also serves as a co-

factor for enzymes such as leucine-amino peptidase.

Low

values of magnesium are encountered in a number of clinical
situations such as in chronic alcoholism, in diabetic
acidosis and in clinical hyperparathyroidism.

Decreased

levels of magnesium may be responsible for production of
various clinical symptoms such as hyper-irritability of
neuromuscular and central nervous system and may frequently
cause cardiovascular abnormalities.

These include tremors,

twitching, hypercative reflexes, mental aberration, ataxia
and hypertension.
Other cations also play an important role in human
metabolism, however they are present in such small amounts
that early workers were unable to measure their precise
concentrations with the analytical methods available at the
time.

For this reason they were often mentioned as occurring

in "traces" and the term trace elements was used to refer
to them.
The first indications that trace elements are of
importance in human physiology were obtained a century ago.
At that time interest centred upon a number of biological
agents which were shown to contain co-ordinated metals not
previously suspected to be of biological significance.
include turacin, a copper containing porphyrin which is

These

found in the feathers of birds ; hemocyanin, a copper containing compound found in the blood of snails • sycotypin,
5
a zinc containing blood pigment found in mollusces

and a

vanadium containing compound present in the blood of sea
squirts^.

In the 19th century, these substances were re-

garded largely as scientific curiosities and their discovery
did little to stimulate studies regarding
the function of
7
the metals.

But in 1885 MacMunn's

investigation on cell

respiration and oxidative processes pointed the way to
studies of metal-enzyme catalysis and of the importance of
a range of trace metal containing metalloenzymes to the
structural and functional integrity of living cells.

During

the first quarter of this century, progress was slow, but
studies were initiated on the importance of iron to human
health and nutrition and several investigations on the metal
composition of plant and animal tissues were undertaken.
After World War II advances in nuclear technology made it
possible to produce radio-active metals, thus the potential
hazard of these materials to living cells became an important issue.

Information on the biological distribution

of stable metals then became a necessary prelude to assessment of the maximum safe levels of radionuclides and their
movements in the food chain.

Extensive investigation were

then carried out on trace element levels in human and
animal tissues.
The second quarter of this century was notable for
spectacular advances in our knowledge of the nutritional
importance of trace elements.

In the early 20's McHargue

of the United States pioneered the purified diet approach

to animal studies.

His findings were most inconclusive

because the purified diets he used were so deficient in
other respects that even with the addition of the metals
under study, the animals usually made poor growth or died.
But in 1928, the Wisconsin group, led by E, B. Hart was
successful in using the purified diet technique to demonstrate that copper is a dietary essential for haemoglobin
formation in the rat.

Within a few years the same group

showed that the dietary intake of manganese and zinc was
also essential for higher animals.

Other workers using the

same techniques showed that molybdenum, selenium and chromium were also essential for life.
During the last 30 years great progress has been made
in our understanding of the mode of action of some of the
trace elements and their metabolic movements within the
animal body.

Most of the trace elements serve a variety of

functions, depending upon their chemical form or combination
and their location in the body tissues and fluids.

For ex-

ample, iodine and cobalt, are two of these elements.

Iodine

is present in thyroxine and cobalt is present in vitamin Bl2
and each is unique to its respective compound.
The oxidation state of the trace elements and their
characteristic concentrations must be maintained within
narrow limits if the function and the structural integrity
of the tissues is to be safeguarded and the growth, health,
and fertility of the animal are to remain unimpaired.

A

trace element deficient, or an excessively high dietary
intake results in biochemical defects and many physiological
functions may be affected.

Structural disorders may arise

which vary with different metals and with the degree and
duration of the dietary deficiency.

Most of the trace ele-

ments function primarily as catalysts for enzymes systems
in the cells .

The roles that the trace elements play in

enzymic reactions range from weak ionic associations, for
example, Zn

2+

and Mn

2+

ions which act as catalysts in cer9

tain hydrolytic enzymes, notably the peptidases , to highly
specified covalently bonded associations known as metalloenzymes.

Some examples of these are carbonic anhydrase, a

zinc metalloenzyme which occurs in erythrocytes; the cytochromes which are iron metalloenzyme which are involved in
electron transport and; pyruvate carboxylase, a manganèse
metalloenzyme, which produces oxalactate from pyruvate.

In

the metalloenzymes the metal is firmly associated with the
protein and there is a fixed number of atoms per molecule
of protein which cannot be removed from this association by
dialysis.

Removal of the metal by more drastic means results

in a loss of enzymic activity which cannot readily be restored by re-addition of the metal.

Some enzyme systems have

less rigid and less specific associations with a metal and
it is more difficult to assign precise metabolic roles to
trace metals.

Malmstrong and Rosenberg^^ defined their

role as:
(1) to induce or maintain the active conformation state of
protein molecule,
(2) to act as a bridge in the formation of a ternary complex,
a purely coordinative role, and
(3) to change the electronic structure of the substrate
molecule.

The trace elements can be divided into three groups as
indicated by Underwood^^:

the essentials; these include

iron, copper, zinc, manganese, cobalt, molybdenum, selenium
and chromium; the possibly essentials; nickel, vanadium,
barium and strontium; and the nonessentials or the toxic
metals, which are toxic to the biological system at relatively low concentrations, these include arsenic, lead,
mercury and cadmium.

This last classification has little

general application because all the trace elements are
toxic if ingested at sufficiently high levels or are in-^
12
gested for an extended period.

According to Cortzias

, a

trace element can be classified as essential if it meets
the following criteria:
(1) it is present in healthy tissues of all living things;
(2) its concentration is fairly constant from one animal
to the next;
(3) its withdrawal from the body induces the same
structural and physiological abnormalities regardless
of the species studied;
(4) its addition either prevents or reverses these
abnormalities;
(5) the abnormalities induced by deficiency are always
accompanied by specific biochemical changes; and
(6) these biochemical changes can be prevented or cured
when the deficiency is rectified.
Absorption of all metals is regulated at the mucosa of
the small intestine.

Knowledge of the mechanism of metal

absorption from the intestine remains fragmentary but it is
suggested that specific proteins of low molecular weight

appear to participate in the process.

A protein associated

with absorption of zinc has been separated and has been
13
shown to have a molecular weight of about 10,000

.

It is

well known that the gut is the site where metals actively
compete with one another for the binding site of the
proteins and that medication with
14 iron depresses the
absorption of copper in infancy

.

Zinc (and probably

iron) f o m poorly soluble ternary complexes with calcium
and phytic acid, and high intakes of calcium in the form
of calcareous clays caused the development of iron deficiency
in Turkish children^^
and iron and zinc deficiency in
16
Iranian children
. Cobalt absorption rises with that of
iron in iron deficiency but cobalt and iron inhibit absorp17
tion of each other
Because of their chemical similarities, cadmium, copper,
silver, andTo zinc
act as antagonists to one another in
1Q 20
metabolism ' ' . They appear to compete for various
binding sites within metabolic systems which include
21
22
intestinal absorptions
. Van Campen
demonstrated that
zinc interacts with copper at a site either in or on the
23 24
intestinal mucosa.

Later workers

'

identified a metal-

binding protein in chick duodenum and suggested that cadmium
and zinc antagonise copper absorption by competing for
binding sites on the intestinal proteins.

These workers

isolated and purified metallothionein from bovine duodenum
and demonstrated that cadmium and zinc displace copper from
sulfhydryl binding sites on the protein. Whanger and
Weswig later presented evidence that cadmium and zinc
25
antagonise copper metabolism within hepatic cells
. They

also demonstrated that plasma ceruplasmin is restored much
more readily in rats fed the low-copper diet than in animals
fed the low-copper diet supplemented with cadmium, silver
and zinc.

They further suggested that these metals in-

hibited ceruplasmin activity by preventing copper from
inducing the aproceruplasmin molecule or by being incorporated
into ceruplasmin in place of copper or a combination of both
mechanisms.

Examinations of the subcellular distribution

of zinc in the liver show that dietary zinc supplements
leads to a decreased concentration of copper within the
microsomes and the soluble fraction while the zinc concentration of these fractions increase significantly.
In a study of the flour beetle^^, it was found that
additional copper slightly reduced the toxic effects of
high levels of both zinc and cadmium and that high level of
zinc reduce the toxicity of cadmium. When cadmium was
added to the diets of chicks, in the presence of additional
copper, zinc or iron, alone or in combination, significant
interactions between the metals were revealed affecting live
weight gains, mortality, red cell counts, haemoglobin levels
and cytochrome oxidase activity in the heart

26

. Comparable

interactions involving cadmium, zinc, copper and iron were
27

subsequently demonstrated in mice and rats

. Cadmium

feeding does not consistently reduce the zinc concentration
in tissue nor does zinc feeding consistently reduce the
cadmium concentrations, even though each 27
element
can anta28 29
gonise the toxicity effects of the other

'

'

. That

these antagonistic effects exist between cadmium and zinc
has been demonstrated in hypertensive patients.

Schroeder^^

has reported that there is a high cadmium/zinc ratio in the
tissues of the hypertensive patients.

When the ratio of

cadmium to zinc in the rat kidney exceed 0.35 on a molar
basis the animal might be expected to exhibit hypertension
because this ratio in kidneys has been correlated with
hypertensive deaths in man

31

.

The injection of disodium

zinc cyclohexane-1, 2-diamine-N, N,N', N'-tetraacetic acid,
lowered the ratio enough to reverse the hypertensive state
by replacing some of the renal and hepatic cadmium with zinc.
The Chinese probably were the first to extract zinc
metal in 1597.

It was orginally sold as "spialter" from

which the industrial name "Spelter" derives, a term which
now applies to less pure zinc.

The element, zinc, has been

estimated to represent 0.004% of the earth's crust and is
the 25th in order of abundance.

Zinc has the atomic number

30 and the atomic weight 65.38.

There are several isotopes,

of which 65

with a half-life of 250 days has been most
zn
widely used for biological studies.
^^^^ ^ much
shorter half-life, 38 minutes has been employed where this
property is a desirable factor, as in therapeutic investi32
gâtions

.

Zinc was first reported to be essential to

animals in 1934 by Wilkert R. Todd et.al. at the University
of Winconsin.

The importance of this element to humans was

not appreciated until 1963, when A. S. Prasad of Wayne State
University reported the 33
effect of zinc deficiency among
adolescent boys in Egypt

.

Zinc is now known to be pre-

sented in at least 90 enzymes.

Some of these metalloenzymes

are pancreatic carboxypeptidase; lactic and glutamic dehydrogenase; alkaline phosphatase; alcohol and malic dehydro-

genases and tryptophan desmolase 11 '32 . Zinc is also
32 34
reported to be present in the hormone insulin

'

which is

produced by the pancreas. Zinc plays an
important role in
the cell division and protein synthesis Of- 'o ¿r . It is also
involved in the functioning of the gonads 32 '37 and the
32
pituitary glands
Zinc is present in serum and erythrocytes, leucocytes
and platelets.

Serum contains about 12%, leucocytes 3% and

erythrocytes 85% of the whole blood zinc.

Almost the whole

of the zinc in erythrocytes is situated in carbonic anhydrase 38 . Carbonic anhydrase cannot be detected in serum or .
leucocytes, so that the zinc in erythrocytes must account
39
for the whole of the activity of this enzyme in blood
Human leucocytes contain a zinc metalloprotein with no
known enzymic activity"^^.

Human blood platelets
contain
Q

zinc in amounts ranging from 0.2 to 0.45 ;ig/lO

platelets.

The serum zinc content is consistently higher than that of
plasma by an average of 16%.

Of this increase, 44% was

demonstrated as being derived from platelets during clotting,
39% from a slightly greater dilution in plasma, and 4% from
haemolysis'^^.

Analysis has been performed
on serum and
42

plasma and was found to be equivalent^ , indicating that
zinc is not removed by clot formation.
Profound changes in zinc content of serum and cellular
elements occur in various diseases.

Subnormal serum zinc

concentrations have been reported in patients with atheros>1 o
clerosis

, with malignant tumor

44
, with myocardial in-

farction"^^, with chronic and acute i n f e c t i o n s ^ w i t h
untreated pernicious a n e m i a ^ a n d with post-alcoholic

cirrhosis of the liver^^'^^.

in patients with anemia other

than pernicious anemia, the zinc and carbonic anhydrase
levels in blood are lowered in parallel fashion so that the
decreases are proportional to the decreases in haemoglobin
and red cell (RBC) remain in normal range.

In pernicious

anemia, however, zinc and carbonic anhydrase values per
51
unit of RBC are found to be significantly above normal
Zinc in trace concentration is essential for growth and
health.
Early microchemical methods 52
such as the use of
diphenylthiocarbazone (Dithizone)
or Zincon (2-carboxy53
2'-hydroxy-5'-sulfo-formalzylbenzene)

for the determination

of zinc in biological fluids are time consuming and tedious.
They usually involve an extraction, ashing and washing with
organic solvents or a precipitation with trichloroacetic
54 55 56
acid to remove protein or other interfering substances ' '
57
before analysis.

The use of emission spectroscopy

zinc determination has been reported.

for

The advantages of

this approach are the high sensitivity and the small sample
size, but the main deterrent for routine application is the
high cost of the equipment.

X-ray fluorescence was first

used for the detection of zinc in biological samples in
1935^^ and the method was later developed for quantitation
of zinc in human tissues^^ and blood serum^^.

Again the

fairly high sensitivity of the method is offset by the cost
of the equipment.

Measurement of zinc in urine, serum and
6l

tissue by polarography

has also been described.

Extensive

cleanup of the sample such as extraction of zinc as the
dithizone complex followed by ashing have to be used before

a measurement can be made.

A f luorometric method for the

determination of zinc in serum and urine has been described
This analysis involves the formation of a 8-quinolinol
complex under alkaline condition after which zinc is determined by a fluorescence measurement at 5l7nm using an
excitation at 375nm.

Under these conditions magnesium and

calcium do not interfere with the zinc measurement.

The

main disadvantage of the procedure are the large sample
volumes and the fall off of fluorescence on sample storage.
Walsh in 1955 described the application of the atomic
absorption technique to chemical analysis

63

. Willis later
64

used the technique for the determination of calcium

,

magnesium^^, sodium and potassium^^ in biological fluids.
Since the method is specific for a given element, atomic
absorption spectrophotometry is very suitable for trace
analysis in biological fluids.

Atomic absorption involves

measurement of the absorption of light by the ground state
of the metal to be determined.

The light source is a

hollow-cathode or arc discharge lamp.

The solution to be

analysed is converted by means of a stream of compressed
air to a fine spray which is mixed with coal gas, propane,
acetylene or hydrogen and the mixture burned in a stainless
steel burner.

The light from the lamp after transversing

the flame, enters a monochromater which has been set at the
wavelength of the resonance line of the metal to be determined and then falls on to a photo-multiplier.

The light

from the lamp is modulated and the signal from the photomultiplier is amplified and the output is read on a meter.
Thus, because of its sensitivity, simplicity and selectivity.

traces of one element can be accurately determined in the
presence of other elements.

Atomic absorption spectroscopy

is an ideal method for the determination of zinc level in
biological fluids.
Zinc is usually firmly bound to the protein present in
the biological fluids.

Therefore, deproteinisation and

extraction procedures are often necessary before an analysis
can be attempted.

Lee et.al.^^ used pyridine-2-aldehyde-2-

pyridyl hydrazone "PATHY" (Fig. 1) to extract the zinc from
serxim. The technique is based on the ability of PATHY to
form stable cationic bis-complexes with zinc, in the +2
oxidation state in an aqueous medium.

When the pH of the

solution is adjusted towards the alkaline side, the charged
complexes attain neutrality and are quantitatively extractable into an organic solvent.

Thus the metals are freed of

the interfering effects of other serum constituents and are
easily quantitated by Atomic Absorption Spectrophotometry.
However, this procedure is lengthy and contamination risks
are high because large sample volumes (1ml) are necessary,
alternatively, zinc analysis by the PATHY route has also
been done by diluting the serum with de-ionised water^® and
69
with metal free buffer

. This modification requires less

sample (0.5ml), and is thus less prone to interference.
Recent developments of non-flame atomization in atomic
absorption spectroscopy offer the opportunity for development of rapid methods for determination of trace metals in
biological materials.

As compared with conventional flame

technique, non-flame atomization permits detection limits
as low as 0.005;ig which are several orders of magnitude

better than the conventional flame method.

This also means

that sample size of the ordeir of micirolitires is enough to
produce a sound analysis, thus simplifying the necessary
pretreatment of biological samples.

One disadvantage of the

non-flame method is matrix interference.

Matrix inter-

ference is most common in measuring low dilutions of serum
.against aqueous standards.
effects.

They give different viscosity

Methods have been published^^ in which aqueous

standards are rendered more viscous by the addition of high
molecular weight substances.

The most commonly used

substance is xylene; when impregnated into the carbon rod
it prevents samples and standards from soaking into the rod
and makes it possible to evaporate them reproducibly from
the inner surface of the transverse bore.

It also improves

reproducibility of measurements of aqueous solutions.
Another disadvantage of the non-flame method is chemical
interference which arises as a result of incomplete dissociation of compounds of the analyte.

Metals differ widely
71

in thier susceptibility to chemical interference

. For

example, calcium is highly prone to interference by phosphate
ion, but this chemical interference can often be minimised
by the use of higher temperature.
72
Use of a sampling boat, which was introduced in 1968
is restricted to the determination of the most volatile
73 74
metals.

The original type of carbon rod

'

does not

provide enough sensitivity for certain biological applications unless operated in the fluorescence mode.

On the

other hand, unless sample is diluted, the heated graphite
tube^^ is much too sensitive for some applications (e.g.

magnesium and zinc) even though less sensitive spectral
lines are chosen.
The new type of carbon rod atomizer operated in the
atomic absorption mode

is even simpler than the original

carbon rod atomizer but gives a better absolute sensitivities
than the heated graphite tube.

Chemical and especially

spectral interference are considerably decreased in comparison
with the original type.

The analytical range of the method

can be considerably extended to higher concentrations by
decreasing the sensitivity through a simple change in experimental conditions.

The new type of carbon rod atomizer

consists of a carbon rod holder and a power unit.

The

carbon rod is clamped in the holder between two water cooled
terminals.

The power unit provides the necessary operating

current for the carbon rod in preselected sequence of drying,
ashing and atomization cycles.

The carbon rod has a trans-

verse bore 1.5mm in diameter, and is made of Ringdoff
77
spectroscopic RWl graphite

. The sample injection hole,

set at an angle of 30° to the longitudinal axis of the rod
but at a right angles to the transverse bore, facilitates
sample deposition.

A sheath of nitrogen is directed around

the rod by a chimney situates beneath.

An attachment for

slit height adjustment is used to mask the continuous
radiations emitted by the incandescent rod.
Before use, the rod is purified by heating to a high
temperature.

Experimental conditions for the drying cycle

are chosen so as to remove solvent in 10 to 20 seconds by
boiling the sample gently to prevent any losses owing to
spluttering.

The ashing is accomplished in 5 to 10 seconds

by heating the rod to temperature lower than that at which
the metal of interest vaporises.

This removes organic

material that would otherwise cause spectral interference
during the subsequent atomization cycle.
This project was concerned with the determination of
serum zinc level in disease and healthy states using the
technique of Atomic Absorption Spectrophotometry with nonflame atomization.

In particular we aimed to determine the

serum zinc level of patients suffering from deep vein
thrombosis before and after zinc therapy and of patients
suffering from acute myocardial infarction.

RESULTS AND DISCUSSION

In a normal healthy individual, the serum zinc level
is relatively constant, about 80 to iSOjag/lOOml.

A zinc

deficiency (45 to TOwg/lOOml) is associated with a number
of clinical symptoms and these include retardation of
g r o w t h ^ ^ ' d i f f i c u l t i e s in wound healing^^; liver
cirrohsis

80

; Sickle Cell anemia

Rl

; metastic carcinoma

83
and acute myocardial infarction

.

The work in this thesis

is concerned with the determination of zinc in the serum of
patients suffering from acute myocardial infarction and
deep vein thrombosis.
In myocardial infarction, the concentration of zinc in
the serum and the
84 injured heart tissue seems to be lower
than in normals

.

The decrease in the zinc level in the

injured heart tissue perhaps relates to the disappearance
of the enzyme lactic dehydrogenase which is a zinc metalloenzyme in the heart tissue.

During acute myocardial

infarction the activity of the enzyme lactic dehydrogenase
in the serum is considerably increased while the serum zinc
level tends to decrease.

This has been ascribed to the

fact that the rate of a reaction catalysed by an enzyme can
be increased by the appearance of
85 the activating substance
or by the removal of inhibitors

.

It has been demonstrated

that the metal which forms part of the lactic dehydrogenase
molecule is necessary for its activity and that it will
greatly inhibit enzyme activity when it is added to the
purified enzyme as a cation.

Subsequent removal of such ion

will markedly activate the enzyme.

Theories have been put

forward to explain the lower zinc levels in serum in acute
myocardial infarction.

In 1972, Pakarek and co-workers

demonstrated the presence of a heat labile, hormone-like
protein in the polymorphonuclear leukocytes which is
released in response to infection or tissue damage.

This

protein acts as a "leukocyte endogenous mediator (LEM)"
and after this factor LEM is liberated from the polymorphonuclear leukocyte, a net flow of amino acids to the liver
is induced which results in an uptake of zinc by the liver
and a decrease in serum zinc.

This finding seems to

suggest that the LEM is the factor responsible for the
decrease of serum zinc level in the acute myocardial
infarction, but whether zinc is coordinated to the amino
acids is not known.
The first experimental evidence that zinc may be
associated with wound healing was provided by an observation
87

by Pories

who was studying the effect of amino acids on

wound healing.

He demonstrated that rats receiving a

phenylalanine analogue in the diet showed an accelerated
wound healing capacity but he had difficulties in reproducing his results.

It was later shown that the improvement

was due to traces of zinc in the diet.

By using radio-

88

active metals

for the study of vascular wound healing, it

was shown that there were marked differences in the
accumulation of various radio-active metals in the healing
artery and zinc was
89 found to be the most active.
It was shown

that there is about three times as much

zinc in the separated nuclei as in the cytoplasm.

The

apparent increase in the erythrocyte-plasma ratio was
suggested to be a consequence of the accumulation of
carbonic anhydrase in erythrocytes^^. ^^Zn penetrates the

hiiman erythrocyte readily, though there is no concomitant
91

increase in carbonic anhydrase activity

. Determinations

of zinc content and carbonic anhydrase activity of human
erythrocytes have suggested that they are mutually dependent
variables.

In a number of pathological conditions, the two

parameters vary in parallel fashion, implying that a large
percentage of the erythrocyte zinc level is due to carbonic
92

anhydrase^ .
In normal persons as well as those afflicted with
anemias, polycythemia-vera, secondary polycythemia, leukemia
and congestive heart failure, both erycythrocyte zinc and
carbonic anhydrase activity vary directly with hematocrit
level and haemoglobin concentration.

In untreated pernicious

anemias, however, the erythrocyte zinc concentration and
carbonic anhydrase activity are nearly normal, although the
hematocrit value, erythrocyte count and haemoglobin levels
are markedly decreased.

The mean corpuscular zinc concen-

tration and carbonic anhydrase activity are increased
several times more than the high mean corpuscular haemoglobin level.

In remission from this disease, zinc concen^ 80

tration and carbonic anhydrase activity return to normal
The direct relationship of erythrocyte zinc levels to
carbonic anhydrase activity 90
of the erythrocyte was first
described by Vallee et. al.

However in the study of

Dennes et. al.^^, in which radioactive ^^Zn uptake by blood
cells was studied it was demonstrated that there is a portion
of erythrocyte zinc which exchanges freely with the body zinc
pool-. This suggests that some zinc is not complexed in any
intimate chemical union with proteins of the cells whereas

the zinc of ca.ir]Donic a.nliyclira.se is closely a.ssodateci with
the enzyme and cannot be dialysed out of the cell even if
94
potent zinc chelating agents are used

.

Therefore it is

not likely that easily exchanged or "labile" zinc could
contribute to the increased concentration
of erythrocyte
95
zinc reported in certain diseases

.

The measured

erythrocyte zinc probably represents the "stable" zinc,
that is, the protein-bound zinc, which is incorporated in
the carbonic anhydrase molecule.

Some workers

have shown

that serum zinc levels are reduced in those clinical
situations in which increased erythrocyte zinc values are
found.

This fact leads to the postulation that the "labile"

zinc in these erythrocytes would decrease, because of the
tendency for the "labile" zinc of the cells to be equilibrated with the body zinc pool.
Erythrocyte zinc tneds to be increased in those 95
clinical states in which leukocyte zinc is decreased
For example, greatly elevated leukocyte zinc was found in
patient with polycythemia vera but erythrocyte
zinc was
96
less than normal.

It has been reported

that serum zinc

may be increased in some cases of polycythemia vera.
Increased binding of zinc erythrocytes may be responsible
for reducing serum zinc in cases of megloblastic anemia,
chronic leukemia, acute lymphocytic leukemia and myeloid
metaplasia.

Decreased serum zinc might be expected to be

reflected first in the leukecytes, because they have rapid
turnover and also because they ordinarily take
up and bind
95
30 tò 75 times more zinc than erythrocytes
In this study the serum zinc values of myocardial

infarction and deep vein thrombosis patients was determined
and compared with normal subjects.

The effect of zinc

supplementation on serum zinc levels and on the clinical
•

state of the patients was also studied.
To establish the normal zinc levels in adult subjects,
venous blood samples from twenty-six females and twentyfour males within the age group of 20 to 60, were obtained
from the Wollongong Hospital Blood Bank.

After collection,

the blood was clotted at room temperature and it was then
centrifuged for 15 minutes.

The serum was then transferred

to a disposable plastic tube and was stored at

Any

specimen which showed even minimal signs of haemolysis was
discarded.

Twenty four hours after collection, the serum

samples were analysed for zinc on an atomic absorption
spectrophotometer fitted with a Carbon Rod Atomiser.

Serum

zinc values were calculated by means of calibration curves
using zinc values of 0.5ug to 1.5ug/ml (Fig. II).
The distribution of normal serum zinc values obtained
from the 26 females and 24 males controls is shown in Table
1.

The mean value for the females was I02ug/l00ml and for

the males I04ug/l00ml respectively.

The variation in zinc

values between the two sexes is less than 0.1 of the
standard deviation, which is not statistically significant.
The mean zinc value for the total of the 50 normals was
105iig/l00ml with a standard deviation of the 28ug/l00ml
giving a range of 82-l28ug/l00ml (Table 2).

Our results

are in agreement v/ith published zinc values (76-125yUg/l00ml)
for normal serum if a correction is made to our values for
the presence of approximately 16% disintegrated platelets

in serum
In order to show the within-run precision of the
analytical method, three serum sample containing 87;ig/l00ml,
lOOjag/lOOml and I20jug/l00ml of zinc respectively were
analysed 10 times.

The results are shown in Table 3, and

show a coefficient of variation of less than 2%.

To

determine the recovery of added zinc, ten serum samples
with a known zinc content taken.

Their concentrations were

80xig/l00ml; 82Mg/l00ml; 85;ug/lQ0ml; 83jag/l00ml7 85Aig/l00ml7
75;ug/lOOml7 95Aig/l00ml; ei^g/lOOml; l03;Lig/l00ml and lllng/
lOOml.

The samples were supplemented with an additional

25jag/l00ml and the samples were then reanalysed. As shown
in Table 4 the average percent recovery was 99%.

The same
98

ten samples were analysed by the dithizone method

to

compare the recovery of added zinc with the carbon rod
technique using atomic absorption spectrophotometry.

As

shown in Table 5 the mean percent recovery was 94% compared
to 99% which was obtained with the atomic absorption method.
A t-test was performed to see whether there is difference
between the two methods.

The t-test gave a value of 0.24,

while in the table of t distribution at 1% confidence limit
for one tailed test with 18 degrees of freedom has a value
of 1-73. Thus, it showed that there was no significant
difference between the results of the carbon rod technique
using atomic absorption spectrophotometry and the dithizone
colorimetric method.

One valuable point which appeared in

this comparision was that the slightly low zinc recovery in
the dithizone method compared with the good recovery of
zinc added in the atomic absorption method was due mostly

to the loss of serum zinc in the original serum samples
because of washing and extracting in the dithizone procedure.
The results reflected the reliability and accuracy of the
. carbon rod technique using atomic absorption spectrophotometry.
In order to confirm that the previously reported
99
observation

that patients suffering from acute myocardial

infarction have a reduced serum zinc level, we analysed the
serum from fifty patients from the Wollongong Hospital who
were undergoing episodes of acute myocardial infarction.
The patients were selected on the basis of known enzyme
activity changes, such as creatine kinases, lactate dehydrogenase and aspartate transaminase.

Five ml of blood was

collected from each patient on the second day after onset
of the myocardial infarction.

In each case the blood was

clotted and immediately centrifuged for 15 minutes and the
serum was then transferred to a disposable plastic tube
which was stored at 4°C.

Serum samples which showed even

minimal sign of haemolysis were discarded. All serum
samples were analysed on the day following collections, and
prior to analysis a standard curve was constructed using
the standard zinc solutions (0.5-1.5;ug/l00ml) . The serum
zinc results obtained from these patients (Table 6) yielded
a mean value of 70;ag/l00ml with a standard deviation of
+21.5.

Our results are in good agreement with the published

data^^^(65jLig/l00ml) obtained by a conventional flame method.
For our study of zinc level in deep vein thrombosis,
50 patients who suffered from this illness were investigated.

Of the 50 patients, 20 of them developed the throm-

bosis after an operation (Group A) and remained hospitalised

in the Wollongong Hospital.

The other 30 patients (Group B)

who has varicose vein disease were admitted to the Wollongong
Hospital.

Blood was collected from each patient and the

samples were analysed for zinc on the day of collection.
The mean value of the set of results were calculated and
they were found to be 72jLig/l00ml for Group A and 67;ug/l00ml
for Group B.

A "t" test was performed to establish if

there were any significant difference in zinc level between
the two groups with a 49 degree of freedom.

The tables of

t distribution for 2 tailed test at 5% significant limits
gave a t value of 0.07, indicating that no significant
difference existed between the two groups.

On the other

hand, the mean zinc value from the 50 patients was 70jLig/
lOOml with a standard deviation of 15 .2;ag/l00ml which gave
a zinc range of 55 .3;ag/l00ml to 85 .7;Lig/l00ml.

This is a

significantly lower value than that obtained from a normal
healthy control group.

A "t" test with 98 degree of freedom

gave a t value of 7.55 which is highly significant.

Again

our results are in agreement with previous reports that
serum zinc levels are decreased in venous leg ulceration
and after surgery.

We have not found any reference to zinc

levels of deep vein thrombosis and thus it seems likely
that low serum zinc levels are associated with thrombosis
like illness, however the mechanism for the depletion of
serum zinc level in this condition is not known.
It is known that 30-40% of zinc in serum is firmly
bound to alpha2-macroglobulin while the remaining zinc seems
to be loosely bound to albumin in normal individuals^^^'^^^.
The amount of zinc of the alpha^-macroglobulin is decreased

in several metabolic neoplastic d i s o r d e r s ^ ^ ^ ' ^ ^ ^ .

it

was shown albumin readily binds ^^Zn while alpha -macroglobulin does not take up ^^Zn or exchange it e a s i l y ^ ^ ^ ' .
Thus the characteristics of alpha^-macroglobulin are in
accord with those of metalloprotein such as ceruplasmin
which contain an atom of copper.

Albumin resembles more

closely a "metal-protein-complex" such as the lactic dehydrogenase molecule^^^.

To establish whether our patient

group suffered from a deficiency in loosely or firmly bound
zinc we carried out an electrophoretic separation on serum
samples from 10 patients using cellulose acetate as a medium.
Before the electrophorectic separation, total protein and
albumin values were estimated by means of a Analyzer using
biuret and bromb-cresol-green respectively.
phoresis pattern is shown in Fig. 3A and 3B.

The electroThe frac-

tionated globulins were tabulated as shwon in Table 9.

The

electrophoretic pattern of this group was compared with a
normal serum and no significant differences were found.

In

T • 0.4. of^ the
4.-U previous
•
•
4. T evidence 102,103,104,106,
light
experimental
the absence of any difference in the relative proportions
of the different electrophoretic fractions suggests that
the decrease in zinc level in the serum of deep vein thrombosis patients may be due instead to a loss of zinc from the
albumin since it normally contains a larger portion of the
loosely bound zinc compared with the other fractions of
^

. 102

protein

To determine the dosage of the zinc supplement, a
discussion was held with the doctors and surgeons at
Wollongong Hospital,

it was known that the average daily

intake of zinc in normal adult is about 10-I5mg and that
about 5mg of the metal is retained.

As a result of the

discussion, it was agreed to supplement the diet of the
patients with l5mg of zinc sulphate.
The 10 patients who suffered from deep vein thrombosis
and who had been admitted to the ward after an operation
were put on such an oral zinc supplement.

This was given to

the patients twice a day in the form of an aqueous solution.
A dose was given in the morning before breakfast and a dose
was given to the patients after dinner at night.

This

routine was maintained for a period of seven days.

In each

case, a blood sample was collected each morning before the
administration of the zinc supplement and a total of eight
samples were collected from each patient.
Zinc analysis by atomic absorption spectrophotometry
showed that this seven day treatment resulted in a significant increase of serum zinc concentration (Table 10).

It

should be noted that serum zinc values of the patients were
slightly increased on the third day but a more significant
(approximately 23%) rise in zinc values was recorded on the
fourth and the fifth day of treatment.

On the seventh and

eighth day a 45% increase of the patients serum zinc concentration was recorded.

These serum values were similar to

those obtained from the serum of the control group.
Absorbed or injected zinc is incorporated at differing
rates into different tissues which reveal varying rates of
zinc turnover.

Uptake of zinc by the bones and CNS is

relatively slow, and the zinc remains firmly bound for long
periods.

The most rapid accumulation and turnover rates of

retained zinc occurs in the pancreas, liver, kidney and
l07 1>08
spleen

'

.

The zinc in these tissues and more slowly

exchanging zinc in muscle and the red cells constitutes a
soft tissue zinc pool composed of compartments of varying
exchange rates.

Cortias^^^' ^^^ showed that various tissues

of mice, as well as various intracellular organells of
mouse liver cells,
show distinct individuality relative to
time course of 65 Zn distribution after intraperitoneal
65
injection.

Injected

Zn combines initially with the serum

proteins to form a serum zinc pool and more slowly with the
intracellular proteins of the cellular components.

Following

oral adminstration the uptake of zinc by the intestinal
mucosa is rapid.

The absorbed zinc is quickly distributed

to combine with" the serum protein to form a serum zinc pool.
Since zinc readily penetrates to the erythrocytes, it will
continue to do so until they are saturated.

The slow

appearance of serum zinc concentration in the patients with
the supplementary zinc diet (the zinc level did not appeared
to increase to significant level until the fourth day of the
administration) could be explained by the red cell taking up
zinc from the initial zinc pool until it reached the normal
level, following which distribution of the zinc to the serum
protein appeared.
After the course of oral supplemention of zinc sulphate,
the patients who suffered from deep vein thrombosis were
generally recovered.

As noted by Dr. Fritzgerald the

pathological conditions of the patients has returned to
normal in terms of red cell counts, white cell differentials,
haemoglobin levels and haemotocrit.

Their general appetites

have improved remarkedly.

The patients were released from

the hospital after two days of the oral supplementation
course.
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TABLE 1
ZINC SERUM LEVELS OF FEMAIE AND MALE CONTROLS
FEMALE

SAMPLES

|ig/lOO ml.

MALE
yUg/100 ml.

1

105

107

2

90

142

3

84

90

4

148

90

5
6

90
86

80
68

7

108

130

8

55

82

9

90

132

10
11

128

112

12

110
96

100
142

13

178

120

14

110

100

15

90

140

16

120

110

17

90

100

18

80

90

19

130

20

84

. 110
112

21

100

130

22

90

80

23

86

110

24

120

120

25

100

26

96
X

= 102

X

= 104

TABLE 2
ZINC SERUM LEVEL OF 50 RANDOM NORMAL SERUM SAMPLES
SAMPLES

TO/10 Onil

SAMPLES

1

105

26

120

2

90

27

110

3

107

28

100

4

84

29

90

5

142

30

140

6

90

31

120

7

148

32

90

8

90

33

80

9

90

34

110

10

80

35

100

11

86

36

130

108

37

90

13

68

38

84

14

55

39

100

15

130

40

110

16

90

41

90

17

128

42

86

18

82

43

120

19

132

44

112

20

110

45

130

21

112

46

100

22

100

47

80

23

96

48

90

24

142

49

100

25

178

50

120

12

..

X = 105

TO/100ml

TABLE 3

WITHIN-RUN PRECISION OF 3 SAMPLES
EACH ANALYSED 10 TIMES USING
THE CARBON-ROD ANALYTICAL METHOD

SAMPLE (jag/lOOml)

X

S .D.

C.V.

87

87.9

1.55

1.76

100

100.2

1.77

1.75

120"

120.2

1.73

1.43

TABLE 4

RECOVERY OF ADDED ZINC IN
10 SERUM SAMPLES WITH CARBON ROD ATOMIZER

SAMPLES

ZINC ADDED

ZINC RECOVERED

Cug/lOOml)

Ug/lOOml)

Ug/lOOml)

80

105

106

101

82

107

105

98

85

110

109

99

83

108

107

99

85

110

111

101

100

99

99

95

120

119

99

61

86

85

99

103

128

127

99

117

142

143

101

75

-

X

=

99%

% RECOVERED

TABLE 5

RECOVERY OF ADDED ZINC IN
10 SERUM SAMPLES WITH DITHIZONE METHOD

SAMPLES
(Mg/lOOml)

ZINC ADDED

ZINC RECOVERED

(;ig/lOOml)

(jLig/lOOml)

% RECOVERED

80

105

99

94

82

107

100

93

85

110

103

94

83

108

102

94

85

110

103

93

75

100

94

93

95

120

113

94

61

86

81

94

103

128

120

94

117

142

133

93

X

=

94%
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TABLE 6
ZINC SERUM VALUE OF PATIENTS SUFFERING
FROM MYOCARDIAL INFARCTION
Samples

>ig/lOOml

Samples

¿15/lOOml

1

46

26

52

2

75

27

47

3

82

28

82

4

116

29

45

5

52

97

6

47

30
31

49

7

52

32

75

8

49

33

78

9

116

34

49

10

59

35

50

11

52

36

64

12

116

37

64

82

38

66

14

73

39

58

15

49

65

16

49

40
41

17

99

42

18

64

43

91
56

19

95

44

50

20

80

45

52

21

94

46"

59

22

60

47

59

23

60

48

110

24

101

49

71

25 .

109

50

50

13

.

X

=

70>ig/100ml

91

39
TABLE 7
ZINC SERUM VALUE OF PATIENTS SUFFERING
FROM DEEP VEIN THROMBOSIS
GROUP A

GROUP B

Samples

Mq/lOOml

Samples

^q/lOOml

1
2
3

110
97
65

1
2
3

105
78
90

4
5

77
67

4
5

56
45

6
7

80
120

6
7

65
75

8

71

8

9

77

9

73
34

10
11

56
67

10
11

82
64

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

45
119
34
64
78
80
64
80
49
49
56
84
67
58
64
78
69

12
13
14
15
16
17
18
19
20

49
64
49
78
67
56

29
30

56
69
X

=

72/Ag/lOOml

69
78
69
•

X

= 67);ig/100ml

TABLE 8

SERUM PROTEIN, ALBUMIN AND GLOBULIN VALUES
OF A GROUP OF 10 PATIENTS

Samples

Total Protein

Albumin

(g/L)

(g/L)

Globulin
(g/L)

1

70

36

34

2

71

36

35

3

74

43

31

4

71

38

33

75

48

27

6

76

43

33

7

78

36

42

8

75

48

27

9

79

37

42

10

72

41

31

5

-

TABLE 9

SERUM PROTEIN ELECTROPHORESIS

DETERMINATION OF ALBUMIN AND FRACTIONATED GLOBULINS

Samples

Albumin

(g/L)

Globulin
Alpha 1

Alpha 2

(g/L)

(g/L)

Beta

Gamma

(g/L)

(g/L)

1

36

2

8

12

13

2

36

3

8

11

13

3

43

2

6

10

13

4

38

2

10

10

11

5

48

2

7

10

8

6

43

2

7

13.

11

7

36

2

8

14

18

8

48

2

7

10

8

9

37

3

9

11

19

10

41

3

6

11

11

TABLE IO

ZINC SERUM VALUES OF PATIENTS
ON ORAL ZINC SULPHATE THERAPY

Zinc Serum Value in >ig/l00ml

Patient
Pre-

Under Treatment

Treatment Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

1

82

84

84

91

97

107

113

114

2

80

85

89

92

100

102

125

128

3

78

85

91

93

99

106

121

125

4

67

80

82

87

101

104

114

118

5

74

78

80

84

94

101

109

110

6

69

72

75

78

94

99

112

114

7

73

74

78

84

97

103

108

110

8

75

78

81

84

92

99

110

112

9

67

72

76

81

91

97

107

110

10

77

80

84

88

99

103

109

119

TABLE 11

MEAN VALUE OF SERUM ZINC OF PATIENTS
ON ORAL ZINC SULPHATE THERAPY

Mean of pre-treatment zinc level

74^g/l00ml

Mean of 4th & 5th day after treatment
zinc level
Mean of 7th day after treatment zinc level

lOljug/lOOml
116y^g/100ml

Increased zinc level after 4 days administration

23%

Increased zinc level after 7 days administration

45%
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(I) Equipment for Zinc Analysis
An atomic absorption spectrophotometer. Model AA6
fitted with a carbon rod atomiser. Model 63 made by
Varian Techtron Pty. Ltd., Melbourne, Australia, was
used for zinc analysis.

The carbon rod atomiser used

consisted of a carbon rod holder and a power unit.

The

carbon rod was clamped in the holder between two water
cooled terminals and the power unit provided the
necessary operating current for the rod in a preselected sequence of drying, ashing and atomisation
cycles.

The atomisation cycle could be operated in

the "step mode" when a constant selected voltage was
for a pre-set period of time, or the "ramp mode" when
the voltage was incremented at a pre-selected rate.
The carbon rod had a transverse bore of 1.5mm in
diameter, and was made of Ringsdorff spectroscopic RWl
graphite.

The sample injection hole, set at an angle

to the transverse bore, facilitated sample deposition.
An attachment for slit height adjustment was used to
mask the continuous radiation emitted by the incadescent
rod.

Hollow-cathode lamps were used for this work, and

the most sensitive analytical resonance lines were
chosen for all determinations.
The carbon rod was adjusted for maximum signal,
so that the only lamp radiation reaching the detector
was that passing through the transverse bore.

If

decreased sensitivity was required the lamp radiation
'was focussed above the rod bore.

Thus, the analytical

range could be considerably extended to higher concen-

trations by decreasing the sensitivity through a simple
change in experimental conditions.

Before use, the rod

was cleaned by heating to a high temperature.

The

sample was then applied to the rod, after which it was
dried, ashed and finally atomised.

Experimental con-

ditions for the drying cycle were chosen so as to
remove any solvent by boiling the sample gently to
prevent any losses owing to spluttering.

The ashing

was accomplished by heating the rod to a temperature
lower than that at which the element vaporised.

This

removed organic material that would otherwise cause
spectral interference during the subsequent atomisation
cycle.

Atomisation was achieved by finally increasing

the temperature of the rod until all the elements to
be measured were vaporised.

The whole procedure was

conducted by the step mode sequence.

Peak signals

were registered on a mV chart recorder.

A microlitre

syringe (S.G.E. type A-RN) was used to deliver 2ul
samples into the carbon rod.
The atomic absorption spectrophotometer setting
were:

lamp intensity of 5mA with the slit width of

0.2nin; gas pressure of nitrogen of 20KPa and hydrogen
of 20KPa.

A wavelength of 213.9nM at the least

sensitive region was used.

This was achieved by

adjusting the carbon rod bore to the height just below
the lamp radiation source so that only minimum light
radiation could get through.

The strip chart recorder

-was monitored at 200mV using a chart speed of 2 inches
per minute.

The gasmeter setting for the inert gas

flow was 6.5 and for fuel input was 1.0.

The settings

of the drying cycle for the step atomisation mode
analysis were 6V for 30 seconds for both aqueous
standard solutions and the serum samples.

While in

the ashing cycle, the time taken for the aqueous
standard solution was shorter than the serum samples
because there were no organics present in the aqueous
solution.

Thus, a setting of 6V for 10 seconds were

used for the aqueous standard solution and a setting
of 6V for 20 seconds were used to analyse serum
samples.

For the atomisation cycle, the same settings,

2.5V for 6 seconds, were used for both the aqueous
standard solution and the serum samples.
(II) Preparation of the Calibration Curve
To establish the zinc calibration curve, a series
of aqueous standard solutions containing 0.25, 0.50,
1.00, 1.25 and 1.50jag/l00ml were analysed in duplicate.
These aqueous standards were made up from a stock
solution of zinc acetate containing Img/ml.

For the

0.5;jig/ml standard, lOul of stock solution was diluted
with 499.90ml of de-ionised water; for the 1.0;ag/ml
standard, 20ul of stock solution was diluted with
499.80ml of de-ionised water; for the 1.25;ig/ml standard,
25ul of stock solution was diluted with 499.75ml deionised water; for the 1.50jag/ml standard, 30ul of
stock solution was diluted with 499.70ml of de-ionised
water; and for the 0.25;ag/ml standard, 250ml of 0.5;jig/ml
- standard solution was diluted with 250ml of de-ionised
water.

Acid washed and dried volumetric flasks (500ml)

were used for all standard solutions and 500ul of
concentrated nitric acid (ISN) was added to each
solution to increase stability.

Before every run, a

water blank was analysed in order to ensure that the
carbon rod was clean.

The values obtained for the

standard solution were plotted and the line of best
fit was drawn (Fig. 2).
(Ill) Within Run Precision
To establish the "within run precision" of the
carbon rod technique, three batches of serum samples
with different zinc concentration were each analysed
10 times.

Serum sample having a value of 87jag/l00ml,

lOOjag/lOOml and l2Q;ag/l00ml of zinc were used.

The

values obtained were tabulated and the mean value was
calculated.

The standard deviation and the coefficient

of variation were calculated (Table 3).
(IV) Reproducibility and Accuracy
A batch of 10 samples containing known zinc values
were used in order to determine the reproducibility
and accuracy of the method.

To do this, 25ul of a zinc

solution of known concentration was added to 10 serum
samples concentration of each and the zinc concentrations
were determined by atomic absorption spectrophotometry.
The strip chart recorder results were read off from
the standard curve and the zinc values were calculated.
The percentage of zinc recovered for each sample was
tabulated (Table 4).
(V)'Dithizone Method
(A) Determination of serum zinc by dithizone method

was based on the method used by A . S. Prasad et.al.^^
All precautions to avoid contamination were carried
out.
used.

Polyethylene test tubes and containers were
De-ionised water was used for preparation of

all reagents.

Acetate buffer at pH6.3 were used.

Chlorophenol red (O.lg in zinc free de-ionised
water) was used as indicator solution.

Seven-

tenth mg per cent dithizone in reagent grade redistilled carbon tetrechloride stored in dark bottle
at

was made up freshly before use.
1ml of serum sample was placed into a centri-

fuge tube.

1ml of zinc free 6NHC1 was delivered

into corresponding numbered set of test tubes.
Then 2ml of 20 per cent trichloracetic acid (TCA)
was added to the serum samples at 90^C in a water
bath and heated for 5 minutes with frequent
stirring until precipitates were finely distributed.
The tubes were cooled and centrifuged at SOOOr.p.m.
for 20 minutes.

After centrifugation, the clear

supernatant fluids were decanted into their corresponding numbered test tubes.

The precipitation

procedure were repeated twice with 2ml of 10 per
cent TCA.

The combined supernatants were then

incubated for 1 hour at 90°C and then transferred
into a 125ml separatory funnels, 1 drop of indicator
was added and was titrated with NH^OH to pH5.5.
Then 50ml of the buffer and lOml of the dithizone
solution were added.

The combined content was

shaken vigorously for 3 minutes.

The organic

phase was read in Beckman spectrophotometer using
CCl^ as blank.
(B) Reagents for the dithizone method were supplied by
Ajax Chemical Pty. Ltd., Australia.

While the

Beckman spectrophotometer Model 24 was supplied by
the Beckman Instruments Inc., Fullerton, California,
92634, U.S.A.
(VI) Collection of Blood Samples
The following equipment was used for the collection
of blood samples:

sterilised disposable syringes (Re-

gional Medical Supply Pty. Ltd., Crows Nest, N.S.W.,
Australia); 21 gauge metal venipunture needles (Regional
Medical Supply Pty. Ltd., Crows Nest, N.S.W., Australia);
sterilised disposable glass pipettes (Scientific Product, McGraw Park, Illinois, U.S.A.); acid washed lOml
sterilised glass centrifuge tubes (Scientific Product,
McGraw Park, Illinois, U.S.A.) and lOml volume disposable plastic tubes (Medical Plastic Pty. Ltd., South
Australia, Australia).
(VII) Collection and Storage of Normal and Patient Blood
Samples
Blood from twenty-six female and twenty-four male
donors were obtained from the Blood Bank of Wollongong
Hospital.

Blood from donors who had not taken drugs

prior to the donation was used.

The blood from

individual patients was collected with a 10ml sterilised
plastic disposable syringe fitted with a size 21 gauge
-metal venipunture needle.

The use of such a sterilised

syringe minimises the possibilities of contamination.

The blood was collected from the vein and was transferred to a lOml acid washed glass centrifuge tube and
was left to clot.

After this the blood from the normal

subjects and the patients was centrifuged for 15
minutes at 3000rpm.

Then, the sera were transferred

to a lOml disposable plastic tube and the samples were
then aliquoted into 1ml portions and the tubes were
capped to prevent evaporation.

The sera were stored

in a refrigerator at 4°C.
(VI11) Equipment for Protein and Albumin Determination
The equipment used for protein and albumin determinations was supplied by Technicon Australia and
consisted of a Technicon Auto-analyser Model II, 6
channel analyser fitted with a strip chart recorder.
(IX) Protein Determination
Serum protein determinations were done by the
Biuret method^^^ using the Auto-analyser II Model.
The reagents used in this method were also supplied by
Technicon Australia.

The reagents used were copper

sulphate, potassium iodide, sodium hydroxide and
potassium-sodium-tartrate.
(X) A j ^ ^ i n Determination
Serum albumin determinations were done by the
bromo-cresol-green method^^^ using the Auto-analyser
Model II.

The reagents:

sodium azide, sodium hydro-

xide, brijj 35 (a detergent solution), succinic acid
and bromo-cresol-green used in this assay were supplied
'by Technicon Australia.

(XI) Equignent used for Protein AnalYsis by _E 1 ectrophore^s
Protein electrophoresis runs were carried out on
a Gelman Densitometer Model No. DCD 16 fitted with a
Gelman Power Pact (Product No. 38206) which was able
to supply a voltage output of 50-500D.C.

The equipment

was supplied by the Gelman Instrument Co., Laboratory
Division, 600 South Wagner Road, Ann Arbor, Michigan,
48106, U.S.A.

The chart paper for the densitometer

was also supplied by the same laboratory.

The following

equipment was supplied by Helena Laboratory, P . O . Box
752, Beaumont, Texas, 77704, U.S.A.:

the Zip-zone

chamber (catalogue No. 1283); Super Z, 8 track applicator capable of delivering lOul of serum of a single
sample (catalogue No. 4088); Super Z sample well-plate
(catalogue No. 4085) which consisted of 8 wells which
could accomodate lOul serum; disposable wicks (catalogue No. 5081); Titan III Zip-zone cellulose acetate
plates (catalogue No. 3023); blotting papers, 3" x 4"
(catalogue No. 5034); plastic bags (catalogue No. 5052)
for storage of the protein electrophoresis plates; and
strip carrying rack (catalogue No. 5110) for delivering
the cellulose acetate plates into the staining solution.
The pipettes (lOul volume) used to deliver the
serum into the applicator was supplied by Oxford
Sampler System (catalogue No. 7000).

A magnetic

stirrer fitted with a hot plate was supplied by
Analite Co., Australia.
Reagents for electrophoresis were supplied by
Helena Laboratory, P . O . Box 752, Beaumont, Texas,

77704, U.S.A.

These were:

a normal serum protein

electrophoresis control (2ml) (catalogue No. 5112); a
serum protein electrophoresis buffer (catalogue No.
300) which consisted of l8g of tris-barbital sodium
barbital which after reconstitution with 750ml of deionised water, yielded a solution of pH 8.0-9.0 and
ionic strength of 0.05; a Ponceau S stain (catalogue
No. 5525), each bottle of which consisted of a 250ml
of 0.5% w/v of Ponceau S in an aqueous solution of 3.5%
w/v sulfosalcylic acid and 3.5% w/v trichloroacetic
acid and patra-clearing aid (catalogue No. 5005) which
contained polyetheneglycol (P.E.G.).
The other two reagents:

Glacial acetic acid (AR)

grade and absolute alcohol (AR) grade were supplied by
Ajax Reagents Co., Sydney, Australia.
(XII) Serum Protein Electrophoresis
Protein electrophoresis was done by the Helena
Laboratory standard method using cellulose acetate.
Before each run, the cellulose acetate strips were
pre-soaked in barbital buffers for at least 4 hours.
The strips were then dried with blotting paper and the
serum samples were applied to the strip by means of
the 8 track applicator.

The strips were then placed

into the separation chamber with the cellulose acetate
side downward touching the buffer soaked wicks.

The

chambers were filled with 50ml of barbital buffer.
The strips were placed into the chamber in such a way
'that the point of application was on the cathode side.
The separation were done in 15 minutes using a voltage

of 180V.

After the run, the strips were taken out of

the separation chamlDer and. were placed in a rack and
stained with the Ponceau S stain solution.

After 10

minutes, the separated protein bands were fixed by the
red stain for scanning.

The strips were washed with

5% acetic acid solution (two times).

The strips were

then soaked in alcohol for 2 minutes, followed by
soaking in Patra-Clear solution for 5 minutes (75% of
absolute alcohol, 20% of acetic acid and 5% of PatraClear) . The strips were then placed on a clean glass
slide with the protein bands facing upwards and they
were then put into an incubator of 45°C for 20-30
minutes.

After drying, the strips were transferred to

a densitometer for protein scanning.
(XIII) Procedure for the Administration of Zinc Sulphate to
Patients and Collection of Blood Samples
A zinc sulphate solution containing I5mg of
hydrated ZnSO^ was given to the patient at 7 a.m.
before breakfast.

Prior to the feeding of the oral

supplement, venous blood (lOml) was drawn from each
patient.

The blood was collected with a sterilised

disposable syringe (lOml) fitted with a metal venipunture needle.

The venous blood was then transferred

to an acid washed glass centrifuge tube and the blood
was allowed to clot and it was then centrifuged for
15 minutes at SOOOrpm.

The unhaemolysed serum was

then transferred to a sterilised plastic disposable
* tube and the serum was stored in a refrigerator at 4°C.
Another dose of zinc sulphate solution was given to

the patient at 9 p.m. and another sample of venous
blood (10ml) was collected next morning.

The same

treatment was repeated for a period of seven days and
eight blood samples were taken from each patient.
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